Measurement of plasma angiotensinogen levels would have been useful in view of the proposed importance of AngII, a breakdown product of angiotensinogen, in accentuating the T2DM risk in men, but these measurements have not been made. This evidence concerns the gene AGT and type 2 diabetes mellitus.